deltatrials
Completed NA INTERVENTIONAL 3-arm NCT01166568

Trial of the PresVIEW Implant for the Improvement of Near Vision in Patients With Presbyopia

A Prospective, Multicenter Clinical Trial Of the PresVIEW Scleral Implant (PSI) For the Improvement Of Near Visual Acuity In Presbyopic Patients

Sponsor: Refocus Group, Inc.

Conditions Presbyopia
Updated 7 times since 2017 Last updated: Aug 31, 2018 Started: Dec 31, 2003 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Presbyopia and is currently completed. Refocus Group, Inc. leads this study, which shows 7 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotCompleted~Oct 2018 – ~Jan 2021 · 27 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Oct 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jun 2018 — Oct 2018 [monthly]

    Completed NA

Show 2 earlier versions
  1. Feb 2017 — Jun 2018 [monthly]

    Completed NA

  2. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Dec 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Refocus Group, Inc.
Data source: Refocus Group, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .